When will exhaled biomarkers influence diagnosis and follow-up of patients with respiratory disease?

Ildikó Horváth (Budapest, Hungary)

Source: International Congress 2015 – The next generation of lung function tests
Session: The next generation of lung function tests
Session type: Symposium
Number: 4451

WebcastSlide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ildikó Horváth (Budapest, Hungary). When will exhaled biomarkers influence diagnosis and follow-up of patients with respiratory disease?. International Congress 2015 – The next generation of lung function tests

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Nuno Manuel Barreiros Neuparth - 26.10.2015 01:35
Very useful to implement new approaches into lung function labs
You must Login to comment this presentation.


Related content which might interest you:
Do exhaled non-invasive inflammatory markers correlate with respiratory symptoms and lung function in a longitudinal study of childhood asthma?
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011


The value of exhaled breath condensate ‘pH‘ to evaluate the severity of disease and the response to treatment in patients with community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

The investigation of the relationship between respiratory exposures and the occurence of the disease in patients with COPD
Source: Annual Congress 2011 - Air pollution
Year: 2011

pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Which is the most effective inflammatory marker in the diagnosis, severity and treatment follow-up of patients with pneumonia?
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Evidence base of lung function indices in diagnosis and follow-up of chronic respiratory diseases in primary care
Source: Annual Congress 2012 - Primary Care Programme
Year: 2012

Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

The influence of smoking on the temperature of the exhaled air in patients with chronic lung diseases
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016



Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

GOLDs definition of COPD in a Norwegian community by self-reported clinical diagnosis of obstructive lung disease and respiratory symptoms
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Is there any relationship between the duration to diagnosis of COPD and severity of the disease?
Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care
Year: 2012


The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO
Source: Annual Congress 2004 - Monitoring childhood asthma
Year: 2004


Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003

Evaluation of changes in exhaled NO during therapy of exacerbation of chronic sinopulmonary diseases in patients with CF or PCD
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009


Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma?
Source: Eur Respir J 2001; 18: 439-441
Year: 2001